Proteinuria: Value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus

British Medical Journal (Clinical research ed.)

Volumn 294, Issue 6588, 1987, Pages 1651-1654

  Borch Johnsen, Knut ^a   Kreiner, Svend ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR MORTALITY; CARDIOVASCULAR SYSTEM; DIABETIC ANGIOPATHY; ENDOCRINE SYSTEM; ETIOLOGY; FATALITY; FORECASTING; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY; PERIPHERAL VASCULAR SYSTEM; PREVENTION; PRIORITY JOURNAL; PROTEINURIA;

ADULT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETIC ANGIOPATHIES; FEMALE; HUMAN; MALE; PREDICTIVE VALUE OF TESTS; PROTEINURIA; RISK; SUPPORT, NON-U.S. GOV'T;

EID: 0023252004     PISSN: 02670623     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.294.6588.1651     Document Type: Article

References (79)

1. Dawber TR. The Framingham study: the epidemiology of atherosclerotic disease. Cambridge, Massachusetts: Harvard University Press, 1980.
2. Brunzell JD, Miller NE. Atherosclerosis in inherited and acquired disorders of plasma lipoprotein metabolism. In: Miller NE, Lewis B, eds. Lipoproteins, atherosclerosis and coronary heart disease. Amsterdam: Elsevier North Holland Biomedical Press, 1981:73-88.
3. Kennedy AL, Lappin TRJ, Lavery TD, Hadden DR, Weaver JA, Montgomery DAD. Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control. Br Med J 1978;ii: 1191-1194.
4. Nikkila FA Hormila P. Senun lipids and lipoproteins in insulin-treated diabetics. Demonstration of increased high density lipoprotein concentrations. Diabetes 1978, 27:1078-1085.
5. Mattock MB, Fuller JH, Maude PS, Keen H. Lipoprotein and plasma cholesterol esterification in normal and diabetic subjects. Atherosclerosis 1979;34:439-449.
6. Durrington PN. Serum high density lipoprotein cholesterol in diabetes mellitus: an analysis of factors which influence its concentration. Clin Chim Acta 1980;104:11-23.
7. Sosenko JM, Breslow JL, Mieltenen DS, Gabbay KH. Hyperglycemia and plasma lipid levels: a prospective study of young insulin dependent diabetic patients. N Engl J Med 1980;302:650-4.
8. Winocour PH, Durrington PN, Ishola M, Anderson DC. Lipoprotein abnormalities in insulin-dependent diabetes mellitus. Lancet 1986;i: 1176-8.
9. Schonfeld G, Birge C, Miller JP, Kellser G, Santiago J. Apolipoprotein B levels and altered lipoprotein composition in diabetes. Diabetes 1974;23:927-34.
10. Nikkila EA. High density lipoprotein in diabetes. Diabetes 1981; 30:82-87.
11. Durrington PN. Serum high density lipoprotein cholesterol subfractions in type 1 (insulin-dependent) diabetes mellitus. Clin Chim Acta 1982;120:21-8.
12. Mattock MB, Salter AM, Fuller JH, et al. High density lipoprotein subfractions in insulin-dependent diabetic and normal subjects. Atherosclerosis 1982;45:67-69.
13. Cruickshank KJ, Orchard TJ, Becker DJ. The cardiovascular risk profile of adolescents with insulin dependent diabetes mellitus. Diabetes Care 1985;8:118-24.
14. Hulley SB, Rosenmann BH, Bawol RD, Brand JJ. The association between triglyceride and coronary heart disease. N Engl J Med 1980;302:1383-9.
15. West KM, Ahuja MMS, Bennett PH, et al. The role of circulating glucose and triglyceride concentrations and their interaction with other “risk factors” as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983;6:361-9.
16. Janka HV. Five year incidence of major macrovascular complications in diabetes mellitus. In: Janka HV, Mehnert H, Standl E, eds. Macrovascular disease in diabetes mellitus, pathogenesis and prevention. Stuttgart, New York: Georg Thieme, 1985:16-9.
17. Havel RJ, Goldstein JL, Brown MS. Lipoproteins and lipid transport. In: Bondy PK, Rosenberg LE, eds. Metabolic control and disease. Philadelphia: W B Saunders, 1980:393-494.
18. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin dependent) diabetes mellitus: an epidemiological study. Diabetologia 1983;25: 496-501.
19. Viberti GC, Hill RD, Jarrett RJ, Argyropoulus A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;i: 1430-2.
20. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent diabetes mellitus). Diabetologia 1985;28:590-6.
21. Short CD, Durrington PN, Mallick NP, Hunt LP, Tetlow L, Ishola M. Serum and urinary high density lipoproteins in glomerular disease with proteinuria. Kidney Int 1986;29:1224-8.
22. Mallick NP, Short CD. The nephrotic syndrome and ischaemic heart disease. Nephron 1981;27:54-57.
23. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in normal serum. J Clin Invest 1955;34:1345-53.
24. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-95.
25. Friedewald WT, Levy R, Fredrickson DS. Estimations of serum low density lipoprotein cholesterol without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
26. Durrington PN, Whicher JT, Warren C, Bolton CH, Hartog M. A comparison of methods for the immuoassay of serum apolipoprotein B in man. Clin Chim Acta 1972;71:95-108.
27. Fielding BA, Price DA, Houlton CA. Enzyme immunoassay for urinary albumin. Clin Chem 1983;29:355-7.
28. Wiseman M, Viberti G, Macintosh D, Jarrett RJ, Keen H. Glycaemia, arterial pressure and microalbuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1984;26:401-5.
29. Mathiesen ER, Oxenboll B, Johansen K, Svendsen PAA, Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetics. Diabetologia 1984;26:406-10.
30. Hasslacher Ch, Stech W, Wahl P, Ritz E. Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1985;26:6-11.
31. Feldt-Rasmussen B. Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1986;29:282-6.
32. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986;314:418-22.
33. Skovborg F. Blood viscosity in normal and diabetic subjects. A clinical-hemorrheological study. Copenhagen: Fad's Forlag, 1974. (PhD thesis.)
34. Valdorf-Hansen W. Coagulability in diabetics. Acta Med Scand 1967;476(suppl);147-57.
35. Vannini P, Giavarella A, Flammini M, et al. Lipid abnormalities in insulin-dependent diabetic patients with albuminuria. Diabetes Care 1984;7:151-4.
36. Eckel RH, McLean E, Albers JJ, Cheung MC, Bierman EL. Plasma lipids and microangiopathy in insulin-dependent diabetes mellitus. Diabetes Care 1981;4:447-53.
37. Durrington PN. A comparison of three methods of measuring serum high density lipoprotein cholesterol in diabetics and non-diabetics. Ann Clin Biochem 1980;17:199-204.
38. Kostner GM. Lipoprotein Lp(a) in man: structure, metabolism and myocardial infarction risk. In: Crepaldi G, LeFebre PJ, Galton DJD, eds. Diabetes, obesity and kyperlipidaemiall. London: Academic Press, 1983:9-14.
39. Kverneland A, Feldt-Rasmussen B, Vidal P, et al. Evidence of changes in renal charge selectivity in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1986;29:634-9.
40. Witztum JL, Fisher M, Metro T, Steinbrecher V, Glam RI. Non-enzymatic glycosylation of high density lipoprotein accelerates its catabolism in guinea pigs. Diabetes 1982;31:1029-34.
41. Glass CK, Pittman RC, Keller GA, Steinberg D. Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem 1983;258:7161-7.
42. Segal P, Gidez LI, Vega G, Edelstein D, Eder HA, Roheim PS. Apoproteins of high density lipoproteins in the urine of normal subjects. J Lipid Res 1979;20:784-8.
43. Shore VG, Forte T, Licht H, Lewis SB. Serum and urinary lipoproteins in the human nephrotic syndrome: evidence for renal catabolism of lipoproteins. Metabolism 1982;31:258-68.
44. Nikkila EA. Triglyceride metabolism in diabetes mellitus. Prog Biochem Pharmacol 1973;8: 271-99.
45. Parving HH, Andersen AR, Smidt UM, Oxenboll B, Edsberg G, Christiansen JS. Diabetic nephropathy and arterial hypertension. Diabetologia 1983;24:10-12.
46. Telmer S, Christiansen JS, Andersen AR, Nerup J, Deckert T. Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 1984;215: 63-8.
47. Nielsen MM, Hjollund E. Smoking and diabetic microangiopathy. Lancet 1978;ii:533-4.
48. retinopathy 53 Mulhauser I, Sawicki P, Berger M. Cigarette smoking as a risk factor for macroproteinuria and in type 1 (insulin-dependent) diabetes. Diabetologia 1986;29:500-2. proliferative
49. Doman TL, Carter RD, Bron AJ, Turner RC, Mann JI. Low density lipoprotein cholesterol: an association with the severity of diabetic retinopathy. Diabetologia 1982;22:167-70.
50. Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982;ii: 1309-11.
51. Green A, Borch-Johnsen K, Andersen PK, et al. Relative mortality of type 1 (insulin-dependent) diabetes in Denmark 1933 to 1981. Diabetologia 1985;28:339-42.
52. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985;28:590-6.
53. Jarrett RJ, Keen H, Chakrabarti R. Diabetes, hyperglycaemia and arterial disease. In: Keen H, Jarrett RJ, eds. Complications of diabetes. London: Edward Arnold, 1982:179-204.
54. Ganda OMP. Pathogenesis of macrovascular disease in the human diabetic. Diabetes 1980;29: 931-42.
55. Jarrett RJ. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease—chicken, egg or neither? Diabetologia 1984;26:99-102.
56. Goodman G. Mortality factors in diabetes. J Occup Med 1975;17:716-21.
57. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984;6:356-60.
58. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrel TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Medicine 1984;1:17-19.
59. Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Deckert T. Declining incidence of proteinuria in type 1 (insulin-dependent) diabetes mellitus. Diabetes (in press).
60. Christau B, Kroman H, Christy M, Ortved Andersen O., Nerup J. Incidence of insulin-dependent diabetes mellitus (0-29 years at onset) in Denmark. Acta Med Scand 1979;624(suppl):54-60.
61. Astrup P, Brochner Mortensen K, Faber M. Clinical laboratory techniques. Copenhagen: August Bang, 1959.
62. Hemmingsen L, Skaarup P. Diagnostic value of a test-strip in detecting increased urinary excretion of albumin, IgG and beta-2-microglobulin in patients with suspected proteinuria. Scand J ClinLab Invest 1981;41:785-9.
63. Skandinavisk Nomenklatur af 1926. D+dsaarsageme i Kongeriget Danmark i aaret 1946. Copenhagen: Fr Bagges Kgl Hofbogtrykkeri, 1947.
64. Kalbfleisch JO, Prentice RW. The statistical analysis of failure time data. New York: Wiley, 1980. 15 Borch-Johnsen K, Kreiner S, Deckert T. Mortality of type 1 (insulin-dependent) diabetes mellitus in Denmark: a study of relative mortality in 2930 Danish type 1 diabetic patients diagnosed from 1933 to 1972. Diabetologia 1986;29:767-72.
65. McCullagh P, Nelder JA. Generalized linear models. London, New York: Chapman and Hall, 1983.
66. Klein R, Klein BEK, Moss SE, Davis MD, De Mets DL. The Wisconsin epidemiology study of diabetic retinopathy: proteinuria and retinopathy in a population of diabetic persons diagnosed prior to 30 years of age. In: Friedman EA, L'Esperance FE, eds. Diabetic renal-retinal syndrome 3. New York: Grune and Stratton, 1986:245-64.
67. Kofoed-Enevoldsen A, Jensen T, Borch-Johnsen K, Deckert T. Development of clinical nephropathy in type 1 (insulin-dependent) diabetic patients implies a high risk for proliferative retinopathy; 22nd annual EASD meeting, Rome, 16-20 September, 1986. Diabetologia 1986;29:559A.
68. Parving H-H, Andersen AR, Smidt UM, Oxenboll B, Edsberg B, Sandahl Christiansen J. Diabetic nephropathy and arterial hypertension. Diabetologia 1983;24:10-12.
69. Christlieb AR. The hypertension of diabetes. Diabetes Care 1982;5:50-58.
70. Lipid Research Clinics Program. The lipid research clinics. Coronary primary prevention trial results. JAMA 1984;251:351-74.
71. Barnett AH, Pyke DA. The genetics of diabetic complications. Clin Endocrinol Metab 1986;15:715-26.
72. Feldt-Rasmussen. B. Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1986;29:282-6.
73. Panzram G, Ruhmann B. Prognose des diabetes mellitus nach friihdiagnose durch glucosuriescreening. Schweiz Med Wochenschr 1978;108:221-5.
74. Waller BF, Palumbo PJ, Lie JT, Roberts WC. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years: analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 1980;69:498-506.
75. Barrett-Connor E, Wingard D. Sex differential in ischemic heart disease in diabetics: a prospective population-based study. Am J Epidemiol 1983;118:489-96.
76. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035-8.
77. Jarrett RJ, ed. The epidemiology of coronary heart disease and related factors in the context of diabetes mellitus and impaired glucose tolerance. In: Diabetes and heart disease. Amsterdam: Elsevier, 1984:1-23.
78. Schroll M, Larsen S. A ten year prospective study, 1964-1974, of cardiovascular risk factors in men and women from the Glostrup population born 1914. Den Med Bull 1981; 28:236-251.
79. Barrett-Connor E, Orchard T. Diabetes and heart disease. In: Harris MI, Hammen RF, eds. Diabetes in America, ser XVI. Washington: National Institute of Health, 1985:1-41. (NIH publication 85-1468.)